PortfoliosLab logoPortfoliosLab logo
VRNA vs. URBN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VRNA vs. URBN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Verona Pharma plc (VRNA) and Urban Outfitters, Inc. (URBN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


VRNA

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

URBN

1D
0.81%
1M
0.53%
YTD
-4.49%
6M
-5.26%
1Y
2.66%
3Y*
29.89%
5Y*
13.70%
10Y*
10.57%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VRNA vs. URBN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VRNA
Verona Pharma plc
0.00%130.21%133.60%-23.92%288.84%-4.00%21.74%-40.41%-18.71%-12.07%
URBN
Urban Outfitters, Inc.
-4.49%37.14%53.77%49.64%-18.77%14.69%-7.81%-16.36%-5.31%47.93%

Correlation

The correlation between VRNA and URBN is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.00

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Apr 27, 2017

0.09

The correlation between VRNA and URBN shifts across timeframes, from -0.00 (1 year) to 0.12 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

VRNA:

$9.72B

URBN:

$6.38B

EPS

VRNA:

-$0.69

URBN:

$5.18

PS Ratio

VRNA:

57.97

URBN:

1.04

PB Ratio

VRNA:

34.92

URBN:

2.45

Total Revenue (TTM)

VRNA:

$167.65M

URBN:

$6.32B

Gross Profit (TTM)

VRNA:

$159.52M

URBN:

$2.27B

EBITDA (TTM)

VRNA:

-$40.86M

URBN:

$603.32M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VRNA vs. URBN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VRNA

URBN
URBN Risk / Return Rank: 4343
Overall Rank
URBN Sharpe Ratio Rank: 4545
Sharpe Ratio Rank
URBN Sortino Ratio Rank: 4141
Sortino Ratio Rank
URBN Omega Ratio Rank: 4040
Omega Ratio Rank
URBN Calmar Ratio Rank: 4545
Calmar Ratio Rank
URBN Martin Ratio Rank: 4444
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VRNA vs. URBN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Verona Pharma plc (VRNA) and Urban Outfitters, Inc. (URBN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

VRNA vs. URBN - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


VRNAURBNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.29

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

0.20

Drawdowns

VRNA vs. URBN - Drawdown Comparison


Loading charts...

Drawdown Indicators


VRNAURBNDifference

Max Drawdown

Largest peak-to-trough decline

-83.96%

Max Drawdown (1Y)

Largest decline over 1 year

-26.32%

Max Drawdown (3Y)

Largest decline over 3 years

-28.53%

Max Drawdown (5Y)

Largest decline over 5 years

-56.36%

Max Drawdown (10Y)

Largest decline over 10 years

-73.80%

Current Drawdown

Current decline from peak

-13.08%

Average Drawdown

Average peak-to-trough decline

-32.57%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.72%

Volatility

VRNA vs. URBN - Volatility Comparison


Loading charts...

Volatility by Period


VRNAURBNDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.02%

Volatility (6M)

Calculated over the trailing 6-month period

28.03%

Volatility (1Y)

Calculated over the trailing 1-year period

43.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

47.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.76%

Dividends

VRNA vs. URBN - Dividend Comparison

Neither VRNA nor URBN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

VRNA vs. URBN - Financials Comparison

This section allows you to compare key financial metrics between Verona Pharma plc and Urban Outfitters, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B2.00B20222023202420252026
75.14M
1.48B
(VRNA) Total Revenue
(URBN) Total Revenue
Values in USD except per share items

VRNA vs. URBN - Profitability Comparison

The chart below illustrates the profitability comparison between Verona Pharma plc and Urban Outfitters, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
95.4%
36.6%
Portfolio components
VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

URBN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Urban Outfitters, Inc. reported a gross profit of 542.57M and revenue of 1.48B. Therefore, the gross margin over that period was 36.6%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

URBN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Urban Outfitters, Inc. reported an operating income of 139.68M and revenue of 1.48B, resulting in an operating margin of 9.4%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

URBN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Urban Outfitters, Inc. reported a net income of 115.71M and revenue of 1.48B, resulting in a net margin of 7.8%.


Frequently Asked Questions


VRNA and URBN have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for VRNA and URBN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer